Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 90 of 123)
- Relevance
  Sort by

Alpha Mannosidosis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4092EUR$4,490USD£3,495GBP

Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

 Report
February 2024
112 Pages
Global

From

€4329EUR$4,750USD£3,697GBP

Cell and Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, II, III, IV), by Indication (Oncology, CNS), by Region (Asia Pacific, North America), and Segment Forecasts, 2022-2030

 Report
June 2022
275 Pages
Global

From

€5422EUR$5,950USD£4,631GBP

Myositis - Pipeline Insight, 2025

 Report
April 2025
80 Pages
Global

From

€1823EUR$2,000USD£1,557GBP

Prostate Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

 Report
August 2022
100 Pages
Global

From

€2278EUR$2,500USD£1,946GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hormone Therapy Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4092EUR$4,490USD£3,495GBP

Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions

 Report
October 2019
427 Pages
Global

From

€4100EUR$4,499USD£3,502GBP

Recombinant Proteins Market by Product, Services, End-User, Function - Global Forecast 2025-2030

 Report
October 2024
185 Pages
Global

From

€3231EUR$3,545USD£2,759GBP

€3590EUR$3,939USD£3,066GBP

Interleukin Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4092EUR$4,490USD£3,495GBP

Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
106 Pages
Global

€4552EUR$4,995USD£3,888GBP

Pediatric Clinical Trials Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
171 Pages
Global

From

€4101EUR$4,500USD£3,503GBP

Primary Immunodeficiency Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2031

 Report
February 2025
150 Pages
Global

From

€4420EUR$4,850USD£3,775GBP

New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4329EUR$4,750USD£3,697GBP

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
150 Pages
Global

From

€4329EUR$4,750USD£3,697GBP

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4329EUR$4,750USD£3,697GBP

Italy Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Italy

From

€4329EUR$4,750USD£3,697GBP

India Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
India

From

€4329EUR$4,750USD£3,697GBP

New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4329EUR$4,750USD£3,697GBP

North America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
North America

From

€4329EUR$4,750USD£3,697GBP

Europe Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Europe

From

€4329EUR$4,750USD£3,697GBP

2,452 Results (Page 90 of 123)
- 1
- 88
- 89
- 90
- 91
- 92

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.